The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, P.-N.
Right arrow Articles by Huber, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, P.-N.
Right arrow Articles by Huber, B. T.
The Journal of Immunology, 2001, 166: 3309-3314.
Copyright © 2001 by The American Association of Immunologists

Association of Mouse Mammary Tumor Virus Superantigen with MHC Class II During Biosynthesis1

Ping-Ning Hsu2,*, Paula Wolf Bryant3,{dagger}, Natalie Sutkowski*, Brian McLellan*, Hidde L. Ploegh{dagger} and Brigitte T. Huber6,*

* Program in Immunology, Department of Pathology, Tufts University School of Medicine, Boston, MA 02111; and {dagger} Department of Pathology, Harvard Medical School, Boston, MA 02115

Mouse mammary tumor viruses encode superantigens that interact with MHC class II proteins and stimulate T cells. We show here that presentation of mouse mammary tumor virus superantigen does not require DM. Furthermore, we have identified a strong class II peptide binding motif in the Mtv-7 superantigen, and we show that this motif is necessary for association with class II molecules in in vitro translation and in vivo functional assays. Our results suggest that endogenously synthesized viral superantigen can bind to MHC class II heterodimers during biosynthesis in the endoplasmic reticulum in a manner analogous to that used by the class II-associated invariant chain.




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. A. Azar, R.-P. Sekaly, and J. Thibodeau
A Defective Viral Superantigen-Presenting Phenotype in HLA-DR Transfectants Is Corrected by CIITA
J. Immunol., June 15, 2005; 174(12): 7548 - 7557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Neumann, A. M. Eis-Hubinger, and N. Koch
Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion
J. Immunol., September 15, 2003; 171(6): 3075 - 3083.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Wirth, A. Vessaz, C. Krummenacher, F. Baribaud, H. Acha-Orbea, and H. Diggelmann
Regions of Mouse Mammary Tumor Virus Superantigen Involved in Interaction with the Major Histocompatibility Complex Class II I-A Molecule
J. Virol., October 2, 2002; 76(21): 11172 - 11175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.